CVE-2022-31049

Cross-Site Scripting in Frontend Login Mailer

Description

TYPO3 is an open source web content management system. Prior to versions 9.5.34 ELTS, 10.4.29, and 11.5.11, user submitted content was used without being properly encoded in HTML emails sent to users. The actually affected components were mail clients used to view those messages. TYPO3 versions 9.5.34 ELTS, 10.4.29, and 11.5.11 contain a fix for the problem.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.51%
Vendor Advisory typo3.org
Affected: TYPO3 typo3
Published at:
Updated at:

References

Link Tags
https://github.com/TYPO3/typo3/security/advisories/GHSA-h4mx-xv96-2jgm third party advisory
https://github.com/TYPO3/typo3/commit/da611775f92102d7602713003f4c79606c8a445d third party advisory patch
https://typo3.org/security/advisory/typo3-core-sa-2022-004 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-31049?
CVE-2022-31049 has been scored as a medium severity vulnerability.
How to fix CVE-2022-31049?
To fix CVE-2022-31049, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-31049 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-31049 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-31049?
CVE-2022-31049 affects TYPO3 typo3.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.